# Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm

> **NCT05538767** · PHASE2 · COMPLETED · sponsor: **Jennifer Keiser** · enrollment: 320 (actual)

## Conditions studied

- Hookworm Infections

## Interventions

- **DRUG:** Emodepside
- **DRUG:** Albendazole 400mg

## Key facts

- **NCT ID:** NCT05538767
- **Lead sponsor:** Jennifer Keiser
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-16
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-04-11
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05538767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05538767, "Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05538767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*